# Solventum Corporation (SOLV)

**Exchange:** NYSE  
**Sector:** Healthcare  
**Market cap:** $14.19B  
**Price:** $80.94 (-1.84%)

> Solventum Corporation is a healthcare company that develops, manufactures, and commercializes solutions leveraging material science, data science, and digital capabilities to address customer and patient needs. It operates through three primary segments: MedSurg, which provides wound therapy, I.V. site management, surgical supplies, medical tapes and wraps, stethoscopes, medical electrodes, and OEM medical technologies; Dental Solutions, offering dental and orthodontic products such as brackets, restorative cements, and bonding agents; and Health Information Systems, delivering software solutions including physician documentation, coding automation, speech recognition, and data visualization platforms. The company serves markets in the United States, where it generates the majority of its revenue, and internationally, focusing on medical instruments and supplies within the healthcare sector. Founded in 2023 and headquartered in Eagan, Minnesota, Solventum Corporation plays a key role in advancing healthcare innovations for medical professionals and patients.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $8.32B | $4.45B | $2.18B | $1.56B | — |
| 2024 | $8.25B | $4.59B | $1.04B | $479M | — |
| 2023 | $8.20B | $4.69B | $1.69B | $1.35B | — |
| 2022 | $8.13B | $4.70B | $1.69B | $1.34B | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $14.29B | $9.24B | $5.05B | $878M | $5.04B |
| 2024 | $14.46B | $11.50B | $2.96B | $762M | $8.01B |
| 2023 | $13.94B | $2.28B | $11.67B | $194M | — |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $369M | $379M | -$10M |
| 2024 | $1.19B | $380M | $805M |
| 2023 | $1.92B | $290M | $1.63B |
| 2022 | $1.68B | $251M | $1.43B |

Source: [CompaniesByCap](https://companiesbycap.com/company/SOLV)
